当前位置:
X-MOL 学术
›
Gland Surgery
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis
Gland Surgery ( IF 1.5 ) Pub Date : 2021-05-27 , DOI: 10.21037/gs-21-16 Rong Tang 1, 2, 3, 4 , Qingcai Meng 1, 2, 3, 4 , Wei Wang 1, 2, 3, 4 , Chen Liang 1, 2, 3, 4 , Jie Hua 1, 2, 3, 4 , Jin Xu 1, 2, 3, 4 , Xianjun Yu 1, 2, 3, 4 , Si Shi 1, 2, 3, 4
中文翻译:
FOLFIRINOX 与吉西他滨加白蛋白结合型紫杉醇在局限性胰腺癌新辅助化疗中的头对头比较:系统评价和荟萃分析
更新日期:2021-05-27
Gland Surgery ( IF 1.5 ) Pub Date : 2021-05-27 , DOI: 10.21037/gs-21-16 Rong Tang 1, 2, 3, 4 , Qingcai Meng 1, 2, 3, 4 , Wei Wang 1, 2, 3, 4 , Chen Liang 1, 2, 3, 4 , Jie Hua 1, 2, 3, 4 , Jin Xu 1, 2, 3, 4 , Xianjun Yu 1, 2, 3, 4 , Si Shi 1, 2, 3, 4
Affiliation
中文翻译:
![](https://static.x-mol.com/jcss/images/paperTranslation.png)
FOLFIRINOX 与吉西他滨加白蛋白结合型紫杉醇在局限性胰腺癌新辅助化疗中的头对头比较:系统评价和荟萃分析